PHAXIAM Therapeutics Statistics
Total Valuation
PHXM has a market cap or net worth of $28.90 million. The enterprise value is $17.92 million.
| Market Cap | 28.90M |
| Enterprise Value | 17.92M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PHXM has 6.40 million shares outstanding. The number of shares has increased by 54.65% in one year.
| Shares Outstanding | 6.40M |
| Shares Change (YoY) | +54.65% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.40 |
| Forward PS | n/a |
| PB Ratio | 0.72 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.78 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.51 |
Financial Efficiency
Return on equity (ROE) is -38.60% and return on invested capital (ROIC) is -29.53%.
| Return on Equity (ROE) | -38.60% |
| Return on Assets (ROA) | -17.30% |
| Return on Capital (ROIC) | -29.53% |
| Revenue Per Employee | $133,931 |
| Profits Per Employee | -$255,775 |
| Employee Count | 49 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.74M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.02% in the last 52 weeks. The beta is 1.96, so PHXM's price volatility has been higher than the market average.
| Beta (1Y) | 1.96 |
| 52-Week Price Change | -65.02% |
| 50-Day Moving Average | 3.38 |
| 200-Day Moving Average | 4.81 |
| Relative Strength Index (RSI) | 42.14 |
| Average Volume (30 Days) | 1,781 |
Short Selling Information
The latest short interest is 2,347, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 2,347 |
| Short Previous Month | 7,475 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | 1.20 |
Income Statement
In the last 12 months, PHXM had revenue of $6.56 million and -$12.53 million in losses. Loss per share was -$3.84.
| Revenue | 6.56M |
| Gross Profit | 6.53M |
| Operating Income | -16.70M |
| Pretax Income | -16.20M |
| Net Income | -12.53M |
| EBITDA | -14.57M |
| EBIT | -15.16M |
| Loss Per Share | -$3.84 |
Balance Sheet
The company has $27.52 million in cash and $16.54 million in debt, giving a net cash position of $10.98 million or $1.71 per share.
| Cash & Cash Equivalents | 27.52M |
| Total Debt | 16.54M |
| Net Cash | 10.98M |
| Net Cash Per Share | $1.71 |
| Equity / Book Value | 40.03M |
| Book Value Per Share | 6.25 |
| Working Capital | 14.79M |
Cash Flow
In the last 12 months, operating cash flow was -$25.09 million and capital expenditures -$143,145, giving a free cash flow of -$25.24 million.
| Operating Cash Flow | -25.09M |
| Capital Expenditures | -143,145 |
| Free Cash Flow | -25.24M |
| FCF Per Share | -$8.14 |
Margins
Gross margin is 99.44%, with operating and profit margins of -254.54% and -190.97%.
| Gross Margin | 99.44% |
| Operating Margin | -254.54% |
| Pretax Margin | -246.91% |
| Profit Margin | -190.97% |
| EBITDA Margin | -221.98% |
| EBIT Margin | -230.99% |
| FCF Margin | -384.56% |
Dividends & Yields
PHXM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.65% |
| Shareholder Yield | -54.65% |
| Earnings Yield | -43.36% |
| FCF Yield | -87.32% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 18, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Sep 18, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PHXM has an Altman Z-Score of -0.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.07 |
| Piotroski F-Score | 3 |